Methods for preventing HIV-1 or HIV-2 infection
AssigneeNew York Blood Center, Inc.
InventorsAlexander R. Neurath, Shibo Jiang, Asim Kumar Debnath
Life of this patent
Estimating the term…
Abstract
A method of preventing HIV-1 or HIV-2 infection by administering to a human a pharmaceutically effective anti-HIV-1 or anti-HIV-2 amount of a tin or silicon protoporphyrin IX or tin or silicon mesoporphyrin IX, or a pharmaceutically acceptable salt thereof.
Claims12
A method of preventing HIV-1 infection or HIV-2 infection comprising locally administering to a human a pharmaceutically effective anti-HIV-1 or anti-HIV-2 amount of a protoporphyrin alone or in admixture with a pharmaceutically acceptable diluent, said protoporphyrin being tin protoporphyrin IX or a pharmaceutically acceptable salt thereof.
A method of preventing HIV-1 infection or HIV-2 infection comprising administering to a human a pharmaceutically effective anti-HIV-1 or anti-HIV-2 amount of tin mesoporphyrin IX or a pharmaceutically acceptable salt thereof alone or in admixture with a pharmaceutically acceptable diluent.
A method of treating HIV-1 infection or HIV-2 infection comprising administering to a human a pharmaceutically effective anti-HIV-1 or anti-HIV-2 amount of a tin mesoporphyrin or a pharmaceutically acceptable salt thereof, alone or in admixture with a pharmaceutically acceptable diluent.
Dependencies are inferred from the claim text.